Sign in to continue:

Wednesday, May 6th, 2026

United Homes Group Executive Compensation, Stock Ownership, and Corporate Governance Overview





United Homes Group, Inc. (UHG) 2025 Annual Report (10-K/A) – Key Investor Highlights

United Homes Group, Inc. (Nasdaq: UHG) Releases Amended 2025 Annual Report: Key Highlights for Investors

United Homes Group, Inc. (“UHG”), a Delaware corporation and a Nasdaq-listed homebuilder, has filed Amendment No. 1 to its Annual Report on Form 10-K (10-K/A) for the fiscal year ended December 31, 2025. This amendment addresses specific disclosure updates primarily in Part III, including executive compensation, governance, related party transactions, and equity compensation plans.

Key Shareholder-Focused Highlights

  • Public Float & Share Structure:
    • As of June 30, 2025, UHG’s public float was approximately \$46.1 million, based on a closing price of \$2.90 per share.
    • As of April 21, 2026, there were 21,853,341 Class A shares and 36,973,876 Class B shares outstanding.
  • Nasdaq Listing:
    • Class A Common Stock (Symbol: UHG) and Warrants (Symbol: UHGWW) are traded on the Nasdaq Stock Market LLC.
  • Issuer Status:
    • UHG is a “non-accelerated filer,” a “smaller reporting company,” and an “emerging growth company.”
    • The company is not a well-known seasoned issuer and is not a shell company.
  • Executive Leadership and Compensation:
    • Jack Micenko is the CEO and President (base salary for 2025 and 2026: \$650,000; 2025 total compensation includes \$385,388 in stock awards and \$20,223 in other compensation).
    • Keith Feldman is CFO (2025 base salary: \$400,000; \$286,800 in stock awards; \$29,554 in other compensation).
    • Michael Nieri serves as Executive Chairman (2025 base salary: \$646,062; \$2,789,242 in nonequity incentive plan compensation; \$31,860 in other compensation).
    • Target bonus opportunities for 2026 for both CEO and CFO are 100% of base salary, based on pretax profit, revenue, and closings.
  • Equity Compensation & Incentive Plans:
    • As of December 31, 2025, there were 6,216,615 shares subject to outstanding options, warrants, and rights under approved equity compensation plans with a weighted average exercise price of \$7.88.
    • 3,436,904 shares remained available for future issuance under equity compensation plans.
  • Beneficial Ownership:
    • Michael Nieri and related trusts remain the largest shareholders, together controlling approximately 42.2% of Class A and 32.6% of Class B shares.
    • Other significant holders include PMN Trust 2018, Fidelity National Financial, Inc., and other institutional investors.
  • Corporate Governance and Ethics:
    • UHG has a Code of Business Conduct and Ethics covering all employees, officers, and directors.
    • Board members, officers, employees, and consultants are prohibited from hedging or pledging company securities and from margin transactions involving UHG securities.
    • 10b5-1 trading plans are permitted for executive officers and directors under strict conditions.
  • Audit Fees:
    • Audit fees for 2025 were \$1,487,498, down from \$1,821,086 in 2024.
    • All audit and non-audit services are subject to pre-approval policies by the Audit Committee.
  • Related Party Transactions:
    • Several related party transactions involving directors, officers, and significant shareholders are disclosed, all subject to Nominating and Corporate Governance Committee review.
  • Restatement and Internal Controls:
    • No restatement of prior financials or material error corrections reported.
    • The company’s auditor did not provide an attestation report on internal control over financial reporting under Section 404(b) of Sarbanes-Oxley.

Potentially Price-Sensitive Information

  • Executive Compensation Structure for 2026: The board has approved a framework for 2026 executive compensation, including significant bonus opportunities directly tied to financial and operational performance. Changes in performance metrics or payouts in 2026 could materially impact the perception of management’s alignment with shareholder interests.
  • Concentration of Ownership: The Nieri family and related trusts continue to control a large percentage of voting shares. This concentration may affect governance outcomes and potential strategic transactions, and could either reassure or concern minority shareholders depending on their view of the controlling group.
  • Equity Compensation Overhang: With over 6.2 million shares subject to options and other equity rights, future dilution is a tangible risk. The weighted average exercise price (\$7.88) is substantially above the year-end market price (\$2.90), but any rally in UHG shares could see significant option exercises and dilution.
  • Emerging Growth Company Status: UHG remains an “emerging growth company,” which comes with reduced reporting and governance requirements. Investors should monitor when and if the company loses this status, as that will impact compliance costs and disclosure obligations.
  • Audit Fees and Controls: The decline in audit fees may reflect efficiencies or changes in business activities; however, investors should monitor internal controls and auditor independence, especially since there is no auditor attestation on internal control effectiveness.
  • No Indication of Restatement or Shell Status: There were no material restatements or shell company issues, which is positive for investor confidence in financial reporting.

Additional Details

  • UHG’s amended 10-K/A was filed solely to update Part III items that were not included in the initial filing. No other sections of the original 10-K have been modified or updated in this amendment.
  • All company policies (Code of Ethics, insider trading, etc.) are available on the investor relations page of the UHG website.
  • Key contracts, governance documents, and executive agreements are incorporated by reference and can be reviewed via SEC filings.

Conclusion

UHG’s Amended 2025 10-K/A provides essential information for investors, especially regarding executive compensation, equity overhang, significant holders, and governance. While there are no restatements or material weaknesses reported, the concentration of ownership, potential for dilution, and performance-based executive pay are all factors that could affect UHG’s share price, particularly if future performance triggers large option exercises or major changes in governance.



Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. The information contained herein is based on the company’s public filings and is believed to be accurate as of the date of publication, but no warranty is made as to its completeness or accuracy.




View United Homes Group, Inc. Historical chart here



AMC Networks Announces Amendments to 10.50% Senior Secured Notes Due 2032 and Extension of Consent Solicitation

AMC Networks Announces Key Amendments to 10.50% Senior Secur...

Agenus Inc. 2025 Annual Report: Immuno-Oncology Strategy, Lead Programs, and Recent Developments

Introduction Agenus Inc. (Nasdaq: AGEN), a biotechnology ...

Bloom Energy Issues Warrant to Oracle for AI Data Center Power Partnership – Form 8-K Filing Details

Bloom Energy 8-K Report: Oracle Warrant Agreement B...

   Ad

Join Our Investing Seminar

Limited seats available — Reserve your spot today